TR200401815T4 - Evcil hayvanlarda pirimidin endotelin antagonistlerinin kullanımı. - Google Patents

Evcil hayvanlarda pirimidin endotelin antagonistlerinin kullanımı.

Info

Publication number
TR200401815T4
TR200401815T4 TR2004/01815T TR200401815T TR200401815T4 TR 200401815 T4 TR200401815 T4 TR 200401815T4 TR 2004/01815 T TR2004/01815 T TR 2004/01815T TR 200401815 T TR200401815 T TR 200401815T TR 200401815 T4 TR200401815 T4 TR 200401815T4
Authority
TR
Turkey
Prior art keywords
domestic animals
pyrimidine
endothelin antagonists
endothelin
antagonists
Prior art date
Application number
TR2004/01815T
Other languages
English (en)
Inventor
Banks J.Bernard
Foster P.Adrian
Gibson P.Stephen
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of TR200401815T4 publication Critical patent/TR200401815T4/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Treatment Of Metals (AREA)

Abstract

Ikame maddelerinin burada tarif edilen degerlere sahip oldugu formül I'in bilesikleri, evcil hayvanlarda özellikle köpekler, kendiler ve atlarda endotelin'in aracilik ettigi bozukluklarin iyilestirilmesinde faydalidir.
TR2004/01815T 2000-02-11 2001-02-06 Evcil hayvanlarda pirimidin endotelin antagonistlerinin kullanımı. TR200401815T4 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0003234.2A GB0003234D0 (en) 2000-02-11 2000-02-11 Method of treatment
PCT/IB2001/000142 WO2001058882A1 (en) 2000-02-11 2001-02-06 Use of pyrimidine endothelin antagonists in companion animals

Publications (1)

Publication Number Publication Date
TR200401815T4 true TR200401815T4 (tr) 2004-08-23

Family

ID=9885465

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/01815T TR200401815T4 (tr) 2000-02-11 2001-02-06 Evcil hayvanlarda pirimidin endotelin antagonistlerinin kullanımı.

Country Status (17)

Country Link
EP (1) EP1254120B1 (tr)
JP (1) JP2003528050A (tr)
KR (1) KR20020075791A (tr)
AT (1) ATE271042T1 (tr)
AU (1) AU3043601A (tr)
CA (1) CA2398007A1 (tr)
DE (1) DE60104283T2 (tr)
DK (1) DK1254120T3 (tr)
ES (1) ES2222975T3 (tr)
GB (1) GB0003234D0 (tr)
HU (1) HUP0204370A3 (tr)
IL (1) IL150488A0 (tr)
NZ (1) NZ519002A (tr)
PT (1) PT1254120E (tr)
TR (1) TR200401815T4 (tr)
WO (1) WO2001058882A1 (tr)
ZA (1) ZA200206343B (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8647660B2 (en) 2004-12-29 2014-02-11 Hill's Pet Nutrition, Inc. Combination of limited nutrients and enhanced dietary antioxidants to impart improved kidney health
RU2376035C2 (ru) * 2005-04-19 2009-12-20 Хилл`С Пет Ньютришн, Инк. Способы и композиции для предотвращения и лечения болезни почек у кошек
ES2570570T3 (es) * 2010-02-25 2016-05-19 Hoffmann La Roche Método para determinar la constante de unión de compuestos de alta afinidad

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0882719B1 (en) * 1995-12-20 2001-05-16 Yamanouchi Pharmaceutical Co. Ltd. Arylethenesulfonamide derivatives and drug composition containing the same
AU8035698A (en) * 1997-06-19 1999-01-04 Yamanouchi Pharmaceutical Co., Ltd. Substituted lower alkanesulfonamide derivatives and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
PT1254120E (pt) 2004-10-29
GB0003234D0 (en) 2000-04-05
NZ519002A (en) 2004-06-25
ES2222975T3 (es) 2005-02-16
CA2398007A1 (en) 2001-08-16
ZA200206343B (en) 2003-08-08
EP1254120B1 (en) 2004-07-14
HUP0204370A2 (en) 2003-05-28
AU3043601A (en) 2001-08-20
HUP0204370A3 (en) 2003-07-28
DE60104283D1 (de) 2004-08-19
JP2003528050A (ja) 2003-09-24
DK1254120T3 (da) 2004-10-04
ATE271042T1 (de) 2004-07-15
WO2001058882A1 (en) 2001-08-16
IL150488A0 (en) 2002-12-01
KR20020075791A (ko) 2002-10-05
DE60104283T2 (de) 2004-11-18
EP1254120A1 (en) 2002-11-06

Similar Documents

Publication Publication Date Title
DK1257175T3 (da) Brug af syrestabile Subtilisin Proteaser i dyrefoder.
YU72002A (sh) Benzoilpirazoli i njihova primena u ulozi herbicida
ATE433978T1 (de) 5,7-diaminopyrazolo 4,3-d pyrimidine zur verwendung in der behandlung von bluthochdruck
BR9916798A (pt) 4-arilamino, 4-arilóxi e 4-ariltio diarilaminas e seus derivados como inibidores seletivos de mek
DK1585737T3 (da) Uraciler med herbicid virkning
PT1332137E (pt) Tratamento de tumores estromais gastrintestinais
ATE362473T1 (de) 1,5-disubstituierte 3,4-dihydro-1h-4,5- döpyrimidin-2-on-verbindungen und ihre verwendung in der behandlung von durch csbp/p38 kinase beeinflussten krankheiten
EA200301100A1 (ru) Новые фталазиноны
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
RS51478B (sr) Upotreba bradikardijskih supstanci u lečenju miokardnih oboljenja povezanih sa hipertrofijom i nove kombinacije lekova
DE69821530D1 (de) Dihydrobenzifurane
DK1463735T3 (da) Imidazo-2,1-B -1,3,4-thiadiazol-sulfonamider
DE60019894D1 (de) Phenantrhridin-n-oxides mit pde-iv hemmender wirkung
ATE391715T1 (de) Heterozyklische mutilinester und deren verwendung als bakterizide
MXPA03011630A (es) Compuestos de amenoacetonitrilo para el control de endoparasitos.
ATE418552T1 (de) Substituierte amino-furan-2-yl-essigsaure- und amino-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
TR200401815T4 (tr) Evcil hayvanlarda pirimidin endotelin antagonistlerinin kullanımı.
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
RS51316B (sr) Nova upotreba (r)-(-)-2-/5-(4-fluorofenil)-3- piridilmetilaminometil/-hromana i njegovih fiziološki prihvatljivih soli
DE60033416D1 (de) Verwendung von hypoestoxiden als antiparasitäre mittel
DE60322110D1 (de) Substituierte 4-(4-piperidin-yl-piperazin-1-yl)-azntagonisten
BR0011330A (pt) 2-aril-1,2,4-triazina-3,5-di(ti)onas substituìdas
DK1051404T3 (da) Substituerede phenyluraciler med herbicid virkning